Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Sensorion Appoints Louis J. Arcudi III as Chief Financial Officer
PRIVATEOct 07, 2026
Position
Chief Financial Officer
Company
Sensorion
Louis J. Arcudi III
MontpellierBiotechnology Research
Description
Sensorion has announced the appointment of Louis J. Arcudi III as its new Chief Financial Officer. This appointment is effective as of October 7, 2026, marking a significant step in the company's leadership.
Company Information
Company
Sensorion
Location
Montpellier, Occitania, France
About
Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders
Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation.
Sensorion has entered into a broad strategic collaboration with Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness including OTOF-GT, targeting deafness caused by a mutation of the gene encoding for otoferlin, and hearing loss related to mutation in GJB2 gene to potentially address important hearing loss segments in adults and children (GJB2-GT).
Fundz sees it the moment Sensorion changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MontpellierBiotechnology Research